| Metric | შპს აბულფარმ | შპს ფარმედ | შპს ალიუდ იუნიტას ჯორჯია | შპს ბერლინ-ჰემი/ა. მენარინი დისთრიბუშენ ჯორჯია |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾341.3m₾134.3m | ₾79.5m₾58.0m | ₾76.8m₾58.2m | ₾73.0m₾50.5m |
| Revenue growth | 154.2% | 37.1% | 31.8% | 44.5% |
| Profitability | ||||
| EBITDA | ₾179.9m₾48.4m | |||
| ₾15.7m₾7.3m |
| ₾2.6m₾1.9m |
| EBITDA margin | 52.7%36.0% | 31.1%26.3% | 20.5%12.5% | 3.6%3.8% |
| Net profit | ₾179.9m₾48.4m | ₾25.2m₾17.2m | ₾469k-₾4.8m | ₾1.8m₾1.5m |
| Net margin | 52.7%36.0% | 31.7%29.6% | 0.6%-8.3% | 2.5%3.0% |
| Balance sheet | ||||
| Total assets | ₾372.9m₾136.8m | ₾90.4m₾67.5m | ₾38.7m₾41.0m | ₾15.8m₾27.4m |
| Total equity | ₾237.4m₾49.7m | ₾77.5m₾52.3m | -₾79.7m-₾80.1m | ₾10.0m₾10.4m |
| ROE | 75.8%97.4% | 32.5%32.8% | — | 18.3%14.4% |